Drug
Ftc Rpv Tdf
Ftc Rpv Tdf: highest development phase Phase 2, developed by Gilead Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Gilead Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| FTC/RPV/TDF NCT01286740 | Phase 2 | HIV-1 Infection |
Latest
No recent events.
Follow Ftc Rpv Tdf on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.